Search

Displaying results 9791 - 9800 of 10000 in total
  1. Drug

    Cefilavancin

    go.drugbank.com/drugs/DB05735
    Investigational

    Cefilavancin is a covalently-linked glycopeptide-cephalosporin (beta-lactam) heterodimer antibiotic that exhibits substantially greater activity than its component parts against Gram-positive bacteria.

  2. Drug

    NF-kappaB Decoy

    go.drugbank.com/drugs/DB05559
    Investigational

  3. Drug

    Facinicline

    go.drugbank.com/drugs/DB05586
    Investigational

  4. Drug

    Talotrexin

    go.drugbank.com/drugs/DB06178
    Investigational

  5. Drug

    AZD3409

    go.drugbank.com/drugs/DB04893
    Experimental

    AZD3409 is a farnesyl-transferase inhibitor (FAR) indicated for the treatment of solid tumors. Phase I trials were initiated January 2003, and were ongoing as of February 2004. As of February 2007 the development of AZD3409 had been disc...

  6. Drug

    Sodium tripolyphosphate

    go.drugbank.com/drugs/DB11493
    InvestigationalVet approved

    Sodium tripolyphosphate is an inorganic compound with formula Na5P3O10 and the sodium salt of the polyphosphate penta-anion.

  7. Drug

    Ficlatuzumab

    go.drugbank.com/drugs/DB11680
    Investigational

    Ficlatuzumab has been used in trials studying the treatment of Acute Myeloid Leukemia, Non-small Cell Lung Cancer, Mullerian Mixed Tumor of Ovary, Relapsed Acute Myeloid Leukemia, and Refractory Acute

  8. Drug

    MW33

    go.drugbank.com/drugs/DB16358
    Experimental

    [L27411] This antibody injection is currently being investigated against COVID-19 in the clinical trial NCT04533048 (A Clinical Study to Evaluate MW33 Injection).

  9. Drug

    Onatasertib

    go.drugbank.com/drugs/DB12570
    Investigational

    Onatasertib (CC-223) has been used in trials studying the treatment and basic science of Multiple Myeloma, Glioblastoma Multiforme, HepatoCellular Carcinoma, Non-small Cell Lung Cancer, and Diffuse Large

  10. Drug

    Lavamilast

    go.drugbank.com/drugs/DB19767
    Experimental

    The usage of the INN stem '-milast' in the name indicates that Lavamilast is a Phosphodiesterase-4 (PDE4) inhibitor. Lavamilast has a monoisotopic molecular weight of 520.16 Da.